Artificial Intelligence | Machine Learning | Machine Perception Diabeloop | Self-Learning Algorithm Solutions for Diabetes Management


Consumer, Diabetes, Health Tech, Medical Technology, Health Assistant Paris , France

Diabeloop

Artificial Intelligence | Machine Learning | Machine Perception


Diabeloop | Self-Learning Algorithm Solutions for Diabetes Management

Diabeloop

Diabetes, Health Tech, Medical Technology, Health Assistant


Paris , France

Since its creation, Diabeloop has been involving people living with Type 1 diabetes and their families. They have contributed to the development alongside engineers and healthcare professionals. The ease of use and intuitive interfaces of personalized solutions developed by Diabeloop is really inspired by patients and their personal experiences. 

In November 2018, Diabeloop’s first medical device, DBLG1, was CE marked. We are working on commercializing, in Europe (France and Germany at first) and later in North America. To support our international ambition and our Research and Development roadmap, we completed a Series B round of funding, setting a European fundraising record for therapeutic artificial intelligence.

Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by this chronic condition from having to make constant therapeutic decisions every day and night and to allow them to live life without interruption.

 

B2C

101 to 250

Series C

$129M

Scaling Up

2015

 
 

Health Care Facilities & Hospitals

Type 1 Diabetes Treatment
Therapeutic Decisions

Increase Productivity
Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing
   Automated Planning and Search


Integrated Care Management

Integrated Care Management

Medical Devices

Medical Devices

Digital Health Platform

Digital Health Platform


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


C ++

C ++

Docker

Docker

GitHub

GitHub

Git

Git

Bitbucket

Bitbucket

Typescript

Typescript

Golang

Golang

Mocha

Mocha

Linux

Linux


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

Apr 2022

  • Diabeloop Leveraged the Diabetes Technology to Enable the Integration of Insulin Pens Into its Hybrid Closed-Loop System
 
 

View All

Global Product Manager

Paris

 

AI/ML Professionals

Want to work at Diabeloop?

We can introduce you to the right person at Diabeloop

Talk to our Talent Team

 

3

1

$75M

Company was founded 2015 and it took almost 7 years (Jun 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

06/02/2022

Series C

$75M

Innovacom, Terumo, LBO France

Date : 06/02/2022

Round: Series C

$ Raised: $75M

Investors: Innovacom, Terumo, LBO France

 

Investors

Interested in researching Diabeloop?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Diabeloop

Request a Demo - Deal Souring Platform

 
Erik Huneker

Erik Huneker
co-founder and CEO

Dr. Guillaume Charpentier

Dr. Guillaume Charpentier
Founder, Chief Medical Officer

Catherine Dunand

Catherine Dunand
President of the board

Capucine Quil

Capucine Quil
Head Of Global Marketing

Cecile Ferracci

Cecile Ferracci
Chief Commercial Officer

Delphine Piotraut

Delphine Piotraut
Head Of Legal

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Diabeloop